Persistent allergic rhinitis Respiratory Vasomotor and allergic rhinitis
Conditions
Interventions
The study includes the following periods in all groups: a run-in period of 1 week before randomisation, a treatment (acupuncture or sham) period of 4 weeks (3 sessions/week), and a follow-up period of
the needle will be inserted to a depth of 3 - 5 mm with a perpendicular direction using hollow pool in a shallow needling technique to avoid de-qi. The needle is then rotated one time in order to pres
Sponsors
Korea Institute of Oriental Medicine (South Korea)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosis of PER, with moderate-severe or severe degree, according to the criteria of Allergic Rhinitis and its Impact on Asthma (ARIA) initiative 2. Completed baseline AR diary and provided written informed consent 3. Aged greater than or equal to 18 years of age, either sex 4. Recruited from each centre by the use of local newspaper advertisements and posted notices at each site 5. Have had PER for greater than 4 days/week, and greater than 4 consecutive weeks
Exclusion criteria
Exclusion criteria: 1. Suffering serious medical conditions such as uncontrolled hypertension, diabetes mellitus requiring insulin injection, past or current malignant tumour, severe dyslipidaemia or liver and kidney dysfunction, anaemia, active pulmonary tuberculosis, other infectious disease or systemic diseases insufficient for acupuncture treatment 2. Congenital nasal abnormalities 3. Sinusitis or active asthma 4. Operation history 5. Received systemically administered corticosteroids within 6 months before enrolment 6. Received alternative and complementary modality, i.e. acupuncture or herbal medication for treating AR within 6 months Topical oral and nasal H1 blockers, or corticosteroid, or nasal anti-cholinergic medication will be stopped before 1 week before enrolment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in self-reported nasal symptoms during 7 days after 12 sessions/4 weeks acupuncture treatment and one-month follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured after 12 sessions/4 weeks acupuncture treatment: 1. Rhinitis Quality of Life Questionnaire (RQLQ) score 2. Total non-nasal symptom score (i.e. headache, itching, pain, eye dropping) Measured during follow-up period: 3. Quantity of conventional relief medication use | — |
Countries
China, Korea, South
Outcome results
None listed